Wellington Management Group’s Fulcrum Therapeutics FULC Stock Holding History

Wellington Management Group’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$910K	Sell	118,600 -27,827	-19%	-$258K	﹤0.01%	1690
2025 Q4	$1.66M	Sell	146,427 -32,931	-18%	-$335K	﹤0.01%	1636
2025 Q3	$1.65M	Buy	179,358 +52,956	+42%	+$383K	﹤0.01%	1682
2025 Q2	$870K	Buy	+126,402	New	+$676K	﹤0.01%	1738
2025 Q1	–	Sell	-172,158	Closed	-$809K	–	1985
2024 Q4	$809K	Sell	172,158 -4,003	-2%	-$14.8K	﹤0.01%	1756
2024 Q3	$629K	Sell	176,161 -6,568	-4%	-$48.7K	﹤0.01%	1788
2024 Q2	$1.13M	Buy	182,729 +10,069	+6%	+$76.3K	﹤0.01%	1648
2024 Q1	$1.63M	Buy	+172,660	New	+$1.54M	﹤0.01%	1571

Other funds holding FULC

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

FTM

First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Wellington Management Group's FULC Position: Q1 2026 in Review

Wellington Management Group reduced its Fulcrum Therapeutics (FULC) stake by 19% in Q1 2026, selling an estimated $258K and leaving 118,600 shares worth $910K. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

Wellington Management Group first reported a position in FULC in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.66M in Q4 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

Wellington Management Group held 118,600 shares of Fulcrum Therapeutics worth $910K as of Q1 2026.
Wellington Management Group sold 27,827 Fulcrum Therapeutics shares in Q1 2026, an estimated $258K.
Fulcrum Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1690 holding.
Wellington Management Group first reported a position in Fulcrum Therapeutics in Q1 2024 and has held it in 8 quarters since.
Wellington Management Group's Fulcrum Therapeutics position peaked at $1.66M in Q4 2025.
169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.